Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-09

Clinical Trial Update: Alfapump-albumin Replacement Therapy [NA]

View source ↗

Summary

The Alfapump-albumin replacement therapy trial sponsored by Sequana Medical in liver cirrhosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfapump

Snippet

Sponsor: Sequana Medical N.V. | Conditions: Liver Cirrhosis | NA | Status: TERMINATED